Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD
- PMID: 19015169
- PMCID: PMC2721428
- DOI: 10.1093/ndt/gfn633
Association of serum bicarbonate levels with mortality in patients with non-dialysis-dependent CKD
Abstract
Background: Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysis-dependent CKD (NDD-CKD).
Methods: We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of pre-dialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD.
Results: Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus > or =22 mmol/L: 1.33 (1.05-1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 26-29 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation.
Conclusions: Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.
Figures




Similar articles
-
Serum bicarbonate and mortality in stage 3 and stage 4 chronic kidney disease.Clin J Am Soc Nephrol. 2011 Oct;6(10):2395-402. doi: 10.2215/CJN.03730411. Epub 2011 Sep 1. Clin J Am Soc Nephrol. 2011. PMID: 21885787 Free PMC article.
-
Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study.BMC Nephrol. 2021 May 19;22(1):185. doi: 10.1186/s12882-021-02385-z. BMC Nephrol. 2021. PMID: 34011303 Free PMC article.
-
Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.Am J Nephrol. 2021;52(4):304-317. doi: 10.1159/000513855. Epub 2021 Apr 23. Am J Nephrol. 2021. PMID: 33895727 Free PMC article.
-
Correction of metabolic acidosis to ameliorate wasting in chronic kidney disease: goals and strategies.Semin Nephrol. 2009 Jan;29(1):67-74. doi: 10.1016/j.semnephrol.2008.10.009. Semin Nephrol. 2009. PMID: 19121476 Review.
-
Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure.Semin Dial. 2004 Nov-Dec;17(6):455-65. doi: 10.1111/j.0894-0959.2004.17606.x. Semin Dial. 2004. PMID: 15660576 Review.
Cited by
-
Serum bicarbonate concentration and the risk of cardiovascular disease and death in type 2 diabetes: the Fremantle Diabetes Study.Cardiovasc Diabetol. 2016 Oct 6;15(1):143. doi: 10.1186/s12933-016-0462-x. Cardiovasc Diabetol. 2016. PMID: 27716263 Free PMC article.
-
Metabolic Acidosis of Chronic Kidney Disease and Cardiovascular Disorders.Maedica (Bucur). 2018 Dec;13(4):267-272. doi: 10.26574/maedica.2018.13.4.267. Maedica (Bucur). 2018. PMID: 30774724 Free PMC article.
-
Bicarbonate, blood pressure, and executive function in pediatric CKD-is there a link?Pediatr Nephrol. 2020 Jul;35(7):1323-1330. doi: 10.1007/s00467-020-04507-5. Epub 2020 Apr 15. Pediatr Nephrol. 2020. PMID: 32297000 Free PMC article.
-
Preservation of kidney function in kidney transplant recipients by alkali therapy (Preserve-Transplant Study): rationale and study protocol.BMC Nephrol. 2018 Jul 13;19(1):177. doi: 10.1186/s12882-018-0956-8. BMC Nephrol. 2018. PMID: 30001705 Free PMC article. Clinical Trial.
-
Sodium bicarbonate therapy in patients with metabolic acidosis.ScientificWorldJournal. 2014;2014:627673. doi: 10.1155/2014/627673. Epub 2014 Oct 21. ScientificWorldJournal. 2014. PMID: 25405229 Free PMC article. Review.
References
-
- Kopple JD, Kalantar-Zadeh K, Mehrotra R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int Suppl. 2005:S21–S27. - PubMed
-
- Kraut JA, Kurtz I. Metabolic acidosis of CKD: diagnosis, clinical characteristics, and treatment. Am J Kidney Dis. 2005;45:978–993. - PubMed
-
- Franch HA, Mitch WE. Catabolism in uremia: the impact of metabolic acidosis. J Am Soc Nephrol. 1998;9:S78–S81. - PubMed
-
- Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Am J Kidney Dis. 2004;44:661–671. - PubMed
-
- Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical